Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis

Background: Cholangiocarcinoma (CCA) has a poor prognosis, and drugs that are effective in subcutaneous xenograft models frequently fail to show clinical benefit. The role of the implantation site in this translational gap remains unclear. Methods: We established intrahepatic orthotopic and subcutaneous xenograft models using the human SCK CCA cell line in BALB/c nude mice. Tumor development was documented by serial gross observation, and subcutaneous tumor growth was quantified using a caliper. At necropsy, tumors were examined macroscopically and by hematoxylin-and-eosin staining and were subjected to bulk RNA sequencing. Differential expression and gene set enrichment analyses were used to compare signaling and metabolic programs, with cross-reference to The Cancer Genome Atlas-Cholangiocarcinoma (TCGA-CHOL) dataset. Results: Orthotopic tumors formed intrahepatic masses with additional intra-abdominal nodules, whereas subcutaneous xenografts formed localized dorsal masses without dissemination. Tumor cell morphology was comparable. Transcriptomic profiling showed concordant upregulation of cell cycle pathways but divergent metabolic programs—downregulation of cholesterol and sterol metabolism in orthotopic tumors versus downregulation of lipid and fatty acid catabolism in subcutaneous tumors. The phosphatidylinositol 3 kinase–protein kinase B (PI3K–AKT) signaling pathway was enriched only in orthotopic tumors. Eleven PI3K–AKT pathway genes upregulated in orthotopic tumors were also upregulated in human CCA tissues in the TCGA-CHOL dataset. Conclusions: Orthotopic and subcutaneous CCA models differ substantially in microenvironment-shaped transcriptional programs. Selective enrichment of PI3K–AKT pathway genes only in orthotopic tumors may explain the discordance between subcutaneous xenograft drug responses and clinical outcomes. Orthotopic implantation may be a more clinically relevant preclinical model.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-18
DOI
https://doi.org/10.3390/cancers18223686
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis

Jae Hee Cho, Sung Ill Jang, Chan Min Jung, Sungsoon Fang et al.
Cancers
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis

Jae Hee Cho, Sung Ill Jang, Chan Min Jung, Sungsoon Fang, Su Yun Lee, Jung Hyun Jo, Ji Hae Nahm, Chae Eun Jang, Ye-Chan Park, Youngmi Song, Jaesun Cha, See Young Lee
article en

Abstract

Background: Cholangiocarcinoma (CCA) has a poor prognosis, and drugs that are effective in subcutaneous xenograft models frequently fail to show clinical benefit. The role of the implantation site in this translational gap remains unclear. Methods: We established intrahepatic orthotopic and subcutaneous xenograft models using the human SCK CCA cell line in BALB/c nude mice. Tumor development was documented by serial gross observation, and subcutaneous tumor growth was quantified using a caliper. At necropsy, tumors were examined macroscopically and by hematoxylin-and-eosin staining and were subjected to bulk RNA sequencing. Differential expression and gene set enrichment analyses were used to compare signaling and metabolic programs, with cross-reference to The Cancer Genome Atlas-Cholangiocarcinoma (TCGA-CHOL) dataset. Results: Orthotopic tumors formed intrahepatic masses with additional intra-abdominal nodules, whereas subcutaneous xenografts formed localized dorsal masses without dissemination. Tumor cell morphology was comparable. Transcriptomic profiling showed concordant upregulation of cell cycle pathways but divergent metabolic programs—downregulation of cholesterol and sterol metabolism in orthotopic tumors versus downregulation of lipid and fatty acid catabolism in subcutaneous tumors. The phosphatidylinositol 3 kinase–protein kinase B (PI3K–AKT) signaling pathway was enriched only in orthotopic tumors. Eleven PI3K–AKT pathway genes upregulated in orthotopic tumors were also upregulated in human CCA tissues in the TCGA-CHOL dataset. Conclusions: Orthotopic and subcutaneous CCA models differ substantially in microenvironment-shaped transcriptional programs. Selective enrichment of PI3K–AKT pathway genes only in orthotopic tumors may explain the discordance between subcutaneous xenograft drug responses and clinical outcomes. Orthotopic implantation may be a more clinically relevant preclinical model.

CancersVol. 18(22)
Yonsei University (KR), Kangbuk Samsung Hospital (KR), Pusan National University Dental Hospital (KR), Gangnam Severance Hospital (KR), Hallym University Dongtan Sacred Heart Hospital (KR), Yonsei University Health System (KR), Pusan National University (KR), Sungkyunkwan University (KR)
National Research Foundation of Korea, Yonsei University College of Medicine
Good health and well-being
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon